Frequency and Benefits of Oxa- 48-Like Gene Detection in Imipenem Resistant Enterobacterales Using Phenotypic Methods

Authors

  • Saeeda Bano Department of Microbiology, Islamic International Medical College Rawalpindi Pakistan
  • Shahina Yasmin Department of Microbiology, Islamic International Medical College Rawalpindi Pakistan
  • Tariq Butt Department of Microbiology, Islamic International Medical College Rawalpindi Pakistan
  • Shazia Taj Department of Microbiology, NUST School of Health Sciences Islamabad Pakistan
  • Nehaj Tariq Department of Microbiology, Wateem Medical College Islamabad Pakistan
  • Aleena Butt Department of Microbiology, Islamic International Medical College Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v75i2.11466

Keywords:

CRE, OXA-48 like, carbaNP, mCIM, eCIM

Abstract

Objectives: To determine frequency of OXA-48 like gene in CRE and to find effectiveness of phenotypic methods for OXA-48 like gene detection.

Study Design: cross-sectional study.

Place and Duration of Study: Pakistan Railway hospital (PRH) Rawalpindi, Pakistan from Oct 2022 to Sep 2023.

Methodology: One hundred and four samples of pus, HVS, urine, sputum was included in the study, inoculated on suitable culture media, and then incubated for 48 hours. Microscopical examination was done after gram staining followed by biochemical testing. Susceptibility of isolates was tested by Disk Diffusion method and MIC of Imipenem was tested against all isolates by using E strips. Carba NP, mCIM, eCIm test were applied on CRE isolates. Isolates found negative for eCIM were tested with temocillin antibiotic disc. Isolates found resistant to temocillin with zone of Inhibition less than 11mm were labelled positive for OXA- 48 like gene.

Results: Out of total 104 CRE isolates 31 (30%) were resistant to temocillin with the sensitivity zone less than 11 mm and were labelled OXA-48 like positive. The frequency of OXA-48 like was determined 30%.

Conclusion: Frequency of OXA-48 like gene was found to be 30%. Phenotypic methods are useful and reliable in the early and speedy detection of OXA-48 like gene in CRE isolates.

Downloads

Download data is not yet available.

References

Estabrook M, Muyldermans A, Sahm D, Pierard D, Stone G, Utt E. Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019. Antimicrob Agents Chemother 2023; 67(5): e01406-22.

https://doi.org/10.1128/aac.01406-22

Canton R, Doi Y, Simner PJ. Treatment of carbapenem-resistant Pseudomonas aeruginosa infections: a case for cefiderocol. Expert Rev Anti infect Ther 2022; 20(8): 1077-1094.

https://doi.org/10.1080/14787210.2022.2071701

Castagnola E, Tatarelli P, Mesini A, Baldelli I, La Masa D, Biassoni R, et al. Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity. J Infect Public Health. 2019; 12(2): 270-274.

https://doi.org/10.1016/j.jiph.2018.11.003

Silvester R, Madhavan A, Kokkat A, Parolla A, Adarsh BM, Harikrishnan M, et al. Global surveillance of antimicrobial resistance and hypervirulence in Klebsiella pneumoniae from LMICs: An in-silico approach. Sci Total Environ 2022; 802: 149859. https://doi.org/10.1016/j.scitotenv.2021.149859

Walsh TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 2010;36: S8-14.

https://doi.org/10.1016/s0924-8579(10)70004-2

Stewart A, Harris P, Henderson A, Paterson D. Treatment of infections by OXA-48-producing Enterobacteriaceae. Antimicrob Agents Chemother 2018; 62(11): 10-128.

https://doi.org/10.1128/aac.01195-18

Koroska F, Göttig S, Kaase M, Steinmann J, Gatermann S, Sommer J, et al. Comparison of phenotypic tests and an immunochromatographic assay and development of a new algorithm for detection of OXA-48-like carbapenemases. J Clin Microbiol 2017; 55(3): 877-883.

https://doi.org/10.1128/JCM.01929-16

Han R, Shi Q, Wu S, Yin D, Peng M, Dong D, et al. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China. Front Cell Infect Microbiol 2020; 10: 314.

https://doi.org/10.3389/fcimb.2020.00314

Laolerd W, Akeda Y, Preeyanon L, Ratthawongjirakul P. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae from Bangkok, Thailand, and their detection by the Carba NP and modified carbapenem inactivation method tests. Microb Drug Resist 2018; 24(7): 1006-1011.

https://doi.org/10.1089/mdr.2018.0080

Rudresh SM, Ravi GS, Sunitha L, Hajira SN, Kalaiarasan E, Harish BN et al. Simple, rapid, and cost-effective modified Carba NP test for carbapenemase detection among Gram-negative bacteria. J Lab Physicians 2017; 9(04): 303-307.

https://doi.org/10.4103/jlp.jlp_138_16

Kamel NA, Tohamy ST, Yahia IS, Aboshanab KM. Insights on the performance of phenotypic tests versus genotypic tests for the detection of carbapenemase-producing Gram-negative bacilli in resource-limited settings. BMC microbiology. 2022; 22(1): 248.

https://doi.org/10.1186/s12866-022-02660-5

Cunningham SA, Limbago B, Traczewski M, Anderson K, Hackel M, Hindler J, et al. Multicenter performance assessment of Carba NP test. J Clin Microbial. 2017 ; 55(6): 1954-1960. https://doi.org/10.1128/JCM.00244-

Bayraktar B, Barış A, Malkoçoğlu G, Erdemir D, Kina N. Comparison of carba NP-direct, carbapenem inactivation method, and β-CARBA tests for detection of carbapenemase production in enterobacteriaceae. Microb. Drug Resist. 2019; 25(1): 97-102.

https://doi.org/10.1089/mdr.2017.0427

Zhu Y, Jia P, Li X, Wang T, Zhang J, Zhang G, et al. Carbapenemase detection by NG-Test CARBA 5—a rapid immunochromatographic assay in carbapenem-resistant Enterobacterales diagnosis. Ann Transl Med 2021; 9(9). https://doi.org/10.21037/atm-20-8216

Huang TD, Poirel L, Bogaerts P, Berhin C, Nordmann P, Glupczynski Y. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers, J Antimicrob Chemother 2014; 69(2): 445-450.https://doi.org/10.1093/jac/dkt367

Mutters NT, Zimmermann S, Kaase M, Mischnik. Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production. Eur J Clin Microbiol Infect Dis 2015; 34: 2429-2437.

https://doi.org/10.1007/s10096-015-2498-3

Hartl R, Widhalm S, Kerschner H, Apfalter P. Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae. Clin Microbiol Infect 2013; 19(5): E230-232. https://doi.org/10.1111/1469-0691.12146

Chan WW, Campbell L, Doyle D, Pitout JD et al. Rapid detection of Enterobacterales that produce carbapenemases. Diagn. Microbiol Infect Dis 2020; 98(2): 115120.

https://doi.org/10.1016/J.DIAGMICROBIO.2020.115120

El Nobi D, Elgendy SG, Bakry R, Hassan AS, El-Sabaa EM. Phenotypic, and genotypic characterization of carbapenemases in carbapenem-resistant gram-negative bacilli isolated from adult cancer patients. Microbes Infect 2023; 4(3): 853-870. https://doi.org/10.21608/mid.2023.219321.1556

Sanmak E, Aksaray S. Comparison of Chromogenic Culture Media, Rapid Immunochromatographic Test and Temocillin Resistance for The Detection of OXA-48 Carbapenemase-Positive Klebsiella pneumoniae Strains. J Clin Trials Exp Investig 2021; 12(4).

https://doi.org/10.29333/jcei/11267

Hopkins KL, Meunier D, Mustafa N, Pike R, Woodford N. Evaluation of temocillin and meropenem MICs as diagnostic markers for OXA-48-like carbapenemases. J Antimicrob Chemother 2019; 74(12): 3641-3642.

https://doi.org/10.1093/jac/dkz383

Downloads

Published

29-04-2025

Issue

Section

Original Articles

How to Cite

1.
Bano S, Yasmin S, Butt T, Taj S, Tariq N, Butt A. Frequency and Benefits of Oxa- 48-Like Gene Detection in Imipenem Resistant Enterobacterales Using Phenotypic Methods. Pak Armed Forces Med J [Internet]. 2025 Apr. 29 [cited 2025 May 1];75(2):359-63. Available from: https://www.pafmj.org/PAFMJ/article/view/11466